Wells Fargo: Milan's Entry into the Fed May Have Limited Impact on the US Dollar
According to a report by Jinse Finance, Wells Fargo strategist Aroop Chatterjee stated that Trump’s economic advisor committee chairman, Milan, may not begin attending Federal Open Market Committee meetings until December, which means he might only participate in two meetings before his term ends, potentially limiting his influence on the US dollar. “Since the Senate is in recess until September, it is currently unclear when he will be able to join the Federal Reserve,” Chatterjee said. “Even if the Senate speeds up the process, attending the December FOMC meeting seems more realistic than September or October. This means Milan will essentially only be able to attend two meetings before his term concludes.”
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage
Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

2-Yr Benchmark Govt Yields - Germany vs Other Nations
2-Yr Benchmark Govt Yields - U.S. vs Other Nations
10-Yr Benchmark Govt Yields - U.S. vs Other Nations
